tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

LCTX Stock Latest News

Lineage Cell Therapeutics’ Earnings Call Highlights Progress and Challenges
Company AnnouncementsLineage Cell Therapeutics’ Earnings Call Highlights Progress and Challenges
26d ago
LCTX
Lineage Cell Therapeutics: Strategic Partnerships and Promising Developments Justify Buy Rating
PremiumRatings
Lineage Cell Therapeutics: Strategic Partnerships and Promising Developments Justify Buy Rating
27d ago
LCTX
Promising Pipeline and Strategic Partnerships Drive Buy Rating for Lineage Cell Therapeutics
PremiumRatings
Promising Pipeline and Strategic Partnerships Drive Buy Rating for Lineage Cell Therapeutics
28d ago
LCTX
Lineage Cell Therapeutics Reports Q1 2025 Financials
PremiumCompany Announcements
Lineage Cell Therapeutics Reports Q1 2025 Financials
28d ago
LCTX
Lineage Cell Therapeutics reports Q1 EPS (2c), consensus (3c)
PremiumThe Fly
Lineage Cell Therapeutics reports Q1 EPS (2c), consensus (3c)
29d ago
LCTX
Lineage Cell announces 36-month results for Phase 1/2a trial of RG6501
PremiumThe FlyLineage Cell announces 36-month results for Phase 1/2a trial of RG6501
30d ago
LCTX
Is LCTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is LCTX a Buy, Before Earnings?
1M ago
LCTX
Lineage Cell Therapeutics price target lowered to $3 from $4 at B. Riley
Premium
The Fly
Lineage Cell Therapeutics price target lowered to $3 from $4 at B. Riley
3M ago
LCTX
Optimistic Outlook for Lineage Cell Therapeutics: Buy Rating Supported by Financial Stability and Strategic Developments
PremiumRatings
Optimistic Outlook for Lineage Cell Therapeutics: Buy Rating Supported by Financial Stability and Strategic Developments
3M ago
LCTX
Lineage Cell Therapeutics Faces Uncertainty Amid New U.S. Administration’s Policies
PremiumCompany Announcements
Lineage Cell Therapeutics Faces Uncertainty Amid New U.S. Administration’s Policies
3M ago
LCTX
Lineage Cell Therapeutics’ Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Lineage Cell Therapeutics’ Earnings Call: Progress Amid Challenges
3M ago
LCTX
Lineage Cell Therapeutics: 2024 Financial Results and Strategic Progress
PremiumCompany Announcements
Lineage Cell Therapeutics: 2024 Financial Results and Strategic Progress
3M ago
LCTX
Options Volatility and Implied Earnings Moves Today, March 10, 2025
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, March 10, 2025
3M ago
FNV
MTN
Options Volatility and Implied Earnings Moves This Week, March 10 – March 14, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 10 – March 14, 2025
3M ago
S
DG
Lineage Cell Therapeutics, Inc. (LCTX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Lineage Cell Therapeutics, Inc. (LCTX) Q4 Earnings Cheat Sheet
3M ago
LCTX
Lineage Therap Issues Private Placement Securities
PremiumCompany Announcements
Lineage Therap Issues Private Placement Securities
4M ago
LCTX
Promising Advancements in Lineage’s OPC1 Program Boost Investor Confidence
PremiumRatings
Promising Advancements in Lineage’s OPC1 Program Boost Investor Confidence
4M ago
LCTX
Lineage Cell Therapeutics initiates study of OPC1 for spinal injury
PremiumThe Fly
Lineage Cell Therapeutics initiates study of OPC1 for spinal injury
4M ago
LCTX
Lineage Therap Secures $66M Funding Through Direct Offering
PremiumCompany Announcements
Lineage Therap Secures $66M Funding Through Direct Offering
4M ago
8K
LCTX
Lineage Cell Therapeutics price target lowered to $3 from $5 at Maxim
PremiumThe FlyLineage Cell Therapeutics price target lowered to $3 from $5 at Maxim
5M ago
LCTX
SANA
Lineage Cell price target lowered to $2 from $3 at D. Boral Capital
Premium
The Fly
Lineage Cell price target lowered to $2 from $3 at D. Boral Capital
5M ago
LCTX
Lineage Cell Therapeutics price target raised to $9 from $7 at H.C. Wainwright
Premium
The Fly
Lineage Cell Therapeutics price target raised to $9 from $7 at H.C. Wainwright
6M ago
LCTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >